HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nathalie Corvaia Selected Research

Injections

3/2013A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibody.
1/2012The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nathalie Corvaia Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 01/2005
2Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 07/2012
1Carcinogenesis
01/2020
1Oncogene Addiction
02/2016
1Neoplasm Metastasis (Metastasis)
01/2013
1Lymphoma (Lymphomas)
07/2012
1Infections
01/2012
1Inflammation (Inflammations)
12/2009
1Virus Diseases (Viral Diseases)
12/2009
1Hypersensitivity (Allergy)
12/2009
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2009
1Melanoma (Melanoma, Malignant)
10/2009
1Breast Neoplasms (Breast Cancer)
01/2005

Drug/Important Bio-Agent (IBA)

6Monoclonal AntibodiesIBA
10/2016 - 12/2009
2Immunoconjugates (Immunoconjugate)IBA
01/2020 - 07/2012
2Junctional Adhesion Molecule AIBA
11/2017 - 03/2013
2Neoplasm Antigens (Tumor Antigens)IBA
10/2016 - 10/2009
2Somatomedin Receptors (Somatomedin Receptor)IBA
01/2013 - 01/2005
1Fenofibrate (CiL)FDA LinkGeneric
01/2022
1Cell Adhesion MoleculesIBA
01/2022
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2020
1auristatinIBA
01/2020
1Insulin-Like PeptidesIBA
01/2020
1Tight Junction ProteinsIBA
11/2017
1LigandsIBA
01/2016
1Chemokine ReceptorsIBA
01/2016
1Pharmaceutical PreparationsIBA
02/2015
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2013
1Biological ProductsIBA
01/2013
1Biosimilar PharmaceuticalsIBA
07/2012
1AntibodiesIBA
07/2012
1obinutuzumabIBA
07/2012
1aluminum sulfate (alum)IBA
01/2012
1TetraspaninsIBA
04/2011
1Proteins (Proteins, Gene)FDA Link
04/2011
1Docetaxel (Taxotere)FDA Link
03/2011
1taxaneIBA
03/2011
1Vincristine (Oncovin)FDA LinkGeneric
03/2011
1AlkaloidsIBA
03/2011
1Immunoglobulins (Immunoglobulin)IBA
12/2009
1Immunoglobulin G (IgG)IBA
12/2009
1Trastuzumab (Herceptin)FDA Link
12/2009
1Cetuximab (Erbitux)FDA Link
12/2009
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2009
1Peptides (Polypeptides)IBA
10/2009
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2009
1MART-1 AntigenIBA
10/2009
1ErbB Receptors (EGF Receptor)IBA
01/2005
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2005
1Growth Factor ReceptorsIBA
01/2005
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2005
1Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2005

Therapy/Procedure

4Therapeutics
03/2013 - 01/2005
2Injections
03/2013 - 01/2012
1Immunotherapy
04/2011
1Biological Therapy
04/2011
1Transplantation
12/2009